FKBP5 and post-traumatic stress disorder: Moreover, some epigenetic changes are potential biomarkers of disease or are valuable for monitoring treatment, e.g., the response of individuals with PTSD to treatment is associated with decreases in the methylation of FKBP5 (FK506-binding protein 5, the protein that binds to and inhibits glucocorticoids) [4].